COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 356: Articles 3551-3560  | Next

Timing and Predictors of Loss of Infectivity among Healthcare Workers with Primary and Recurrent COVID-19: a Prospective Observational Cohort Study
Dzieciolowska, S., Charest, H., Roy, T., Fafard, J., Carazo, S., Levade, I., Longtin, J., Parkes, L., Beaulac, S. N., Villeneuve, J., Savard, P., Corbeil, J., De Serres, G., Longtin, Y.
10.1101/2023.06.16.23291449 — Posted: 2023-06-18
Mitigating the psychological impacts of COVID-19 restrictions on older people: The UK Behavioural Activation in Social Isolation (BASIL+) COVID-19 Urgent Public Health (UPH) trial and living systematic review
Gilbody, S., Littlewood, E., McMillan, D., Atha, L., Bailey, D., Baird, K., Gascoyne, S., Burke, L., Chew-Graham, C. A., Coventry, P., Crosland, S., Fairhurst, C., Henry, A., Hollingsworth, K., Newbronner, E., Ryde, E., Shearsmith, L., Wang, H.-i., Webster, J., Woodhouse, R., Clegg, A., Dexter Smith, S., Gentry, T., Hewitt, C., Hill, A., Lovell, K., Sloan, C., Traviss-Turner, G., Pratt, S., Ekers, D.
10.1101/2023.06.13.23291329 — Posted: 2023-06-18
Evaluation of 3-D printed swabs for respiratory sampling and testing for SARS-CoV-2 during the early pandemic period
Hasan, Z., Iqbal, A., Ahmed, I., Khan, M., Jabeen, K., Islam, N., Khan, E., Sayani, S.
10.1101/2023.06.14.23291367 — Posted: 2023-06-16
Tracking SARS-CoV-2 seropositivity in rural communities using blood-fed mosquitoes
Krajacich, B. J., Samake, D., Dao, A., Diallo, M., Sanogo, Z. L., Yaro, A. S., Ziguime, A., Poudiougo, J., Cisse, K., Traore, M., dit Assitoun, A., Faiman, R., Zaidi, I., Woodford, J., Duffy, P. E., Lehmann, T.
10.1101/2023.06.13.23291267 — Posted: 2023-06-16
Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: a 2-year follow-up study
Elias, T. P., Gebreamlak, T. W., Gebremeskel, T. T., Adde, B. L., Elias, B. P., Argaw, A. M., Tenaw, A. A.
10.1101/2023.06.13.23290674 — Posted: 2023-06-16
Omicron vs. the Rest: Assessing the Competitive Dynamics and Coinfection Scenarios of COVID-19 Strains on a Social Network
Jebraeilian, H., Jamali, Y.
10.1101/2023.06.13.23291332 — Posted: 2023-06-16
Repurposing Remdesivir for COVID-19: Computational Drug Design Targeting SARS-CoV-2 RNA Polymerase and Main Protease using Molecular Dynamics Approach
Shikder, M., Ahmed, K. A., Moin, A. T., Patil, R. B., Hasib, T. A., Hossan, M. I., Mahasin, D., Sakib, M. N., Ahmed, I., Patel, H., Chowdhury, A. S.
10.1101/2023.06.15.545129 — Posted: 2023-06-16
High-confidence placement of difficult-to-fit fragments into electron density by using anomalous signals - a case study using hits targeting SARS-CoV-2 non-structural protein 1
Kozielski, F. G., Ma, S., Bowler, M. W., Mykhaylyk, V., Pinotsis, N.
10.1101/2023.06.16.545251 — Posted: 2023-06-16
SARS-CoV-2 Delta Variant Remains Viable in Environmental Biofilms found in Meat Packaging Plants
Chitlapilly Dass, S., Featherstone, A. B., Mathijssen, A. J., Brown, A. C.
10.1101/2023.06.15.545172 — Posted: 2023-06-16
Inflammatory profiles are associated with long COVID up to 6 months after illness onset: a prospective cohort study of individuals with mild to critical COVID-19
Wynberg, E., Han, A. X., van Willigen, H. D. G., Verveen, A., van Pul, L., Maurer, I., van Leeuwen, E. M., van den Aardweg, J. G., de Jong, M., Nieuwkerk, P. T., Prins, M., Kootstra, N. A., de Bree, G. J., The RECoVERED Study Group
10.1101/2023.06.14.23291395 — Posted: 2023-06-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).